Goodman Advisory Group, LLC Merck & Co., Inc. Transaction History

Goodman Advisory Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$102.95 - $114.33 $4,529 - $5,030	-44 Reduced 25.73%	127 $13,000
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $449,754 - $490,211	-4,141 Reduced 96.03%	171 $19,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $2.59 Million - $2.89 Million	-25,162 Reduced 85.37%	4,312 $458,000
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $59,371 - $76,122	-679 Reduced 2.25%	29,474 $3.27 Million
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $755,529 - $848,752	-8,938 Reduced 22.86%	30,153 $2.6 Million
Q2 2022 Aug 03, 2022	BUY	$83.49 - $94.64 $3.26 Million - $3.7 Million	39,091 New	39,091 $3.56 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Goodman Advisory Group, LLC with notifications on news.